Winn-Dixie launches ‘Shield Yourself’ flu vaccination campaign
JACKSONVILLE, Fla. — Winn-Dixie Stores on Monday kicked off its “Shield Yourself” flu vaccination campaign offering consumers three options in getting this year’s influenza vaccine.
Guests at any of the grocer’s in-store pharmacies can choose from the standard vaccination, a high-dose vaccine recommended for those 65 years and older or an Intradermal flu vaccination administered with a microneedle that is 90% smaller than traditional needles, Winn-Dixie stated.
“We have the flu vaccine now and offer guests quick and easy options to receive it while they do their grocery shopping," stated John Fegan, Winn-Dixie VP pharmacy. "With the start of school, now is the perfect time to shield your health with a flu shot.”
Fegan noted that Winn-Dixie pharmacists will be recommending that patients wash hands frequently and wipe down telephones, remote controls and door knobs with disinfectant to help stop any spread of cold and flu viruses.
Winn-Dixie patients receiving a flu vaccination will receive a coupon book with $15 in savings on products like hand sanitizer, disenfectants and tissues, while supplies last.
Crain’s: Klaff Realty eyeing Supervalu’s Jewel-Osco business
CHICAGO — Suitors are lining up to carve out divisions of Supervalu following the company’s announcement last month that strategic divestitures were on the table as the Eden Prairie, Minn.-based grocer seeks to turn around its business performance. A Crain’s report published Monday identified Klaff Realty as one of the first companies to express an interest, in this case the Jewel-Osco piece of the business.
According to the report, Jewel-Osco competitor Dominick’s is also a likely suitor for that piece of Supervalu’s portfolio. The report also noted that Kroger could benefit from acquiring parts of Supervalu.
For the full Crain’s report, click here.
Prasco, Sunovion enter agreement over Xopenex authorized generic
CINCINNATI, Ohio — Prasco Labs is distributing an authorized generic version of a respiratory drug under an agreement with the branded drug’s manufacturer.
Prasco said Monday that it had entered an agreement with Sunovion Pharmaceuticals to distribute an authorized generic version of Sunovion’s Xopenex (levalbuterol hydrochloride) inhalation solution in the 1.25-mg/3-mL, 0.63-mg/3-mL and 0.31-mg/3-mL strengths. An authorized generic is a branded drug marketed under its generic name at a reduced price, usually under a partnership between the branded drug’s manufacturer and a third-party company.
Xopenex is used to treat and prevent bronchospasm in patients ages 6 years and older with reversible obstructive airway disease. Xopenex had sales of about $474 million during the 12-month period ended in June, according to IMS Health.